Abingworth
John Chiminski serves as Chair and CEO of Catalent, Inc. (NYSE CTLT), a global healthcare development company with sales of $3.1b and over 14,000 employees, which he has led since 2009. He joined Catalent after more than 20 years of experience at GE Healthcare in engineering, operations, and senior leadership roles. Before Catalent John was President and CEO of GE Medical Diagnostics., a global business with sales of $1.9 billion.
John has served as a Director of Berkeley Lights since May 2021.
BS from Michigan State University and MS from Purdue University, both in electrical engineering; Master’s Degree in Management, Kellogg School of Management at Northwestern University.
This person is not in the org chart
This person is not in any offices
Abingworth
1 followers
Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs to develop their ideas into products that have a dramatic impact on health. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies, and across all life sciences sectors. Supporting its portfolio companies with a team of 25 at offices in London, Menlo Park, and Boston, Abingworth has invested in 151 life science companies, completed 65 IPOs and 42 mergers and acquisitions.